Skip to main content
Pharmaron Beijing Co., Ltd. logo

Pharmaron Beijing Co., Ltd. — Investor Relations & Filings

Ticker · 300759 ISIN · CNE100003JW4 LEI · 300300JYXHGVS5SNGG54 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2025-10-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300759

About Pharmaron Beijing Co., Ltd.

https://www.pharmaron.cn

Pharmaron Beijing Co., Ltd. is a premier R&D service provider for the life sciences industry, offering a comprehensive, fully integrated platform for drug discovery, development, and manufacturing. The company supports global pharmaceutical and biotechnology partners through a wide range of services, including laboratory chemistry, biology, DMPK, pharmacology, and safety assessment. Its capabilities extend to clinical development services and commercial-scale manufacturing for small molecules, biologics, and cell and gene therapies. By leveraging advanced technology and a global network of facilities, the company facilitates the transition of drug candidates from initial concept to market approval, optimizing the efficiency and success of the drug development lifecycle.

Recent filings

Filing Released Lang Actions
候选人声明与承诺
Board/Management Information Classification · 95% confidence The document is a formal declaration and commitment statement by an independent director candidate for a company's board. It details the candidate's qualifications, compliance with regulatory requirements, and commitments related to the role of an independent director. There are no financial statements, earnings data, or report summaries. The content is focused on board/management information, specifically about a director candidate's eligibility and declarations. This fits the category of Board/Management Information (MANG). The document length is 4328 characters, which is sufficient for a detailed declaration but not a full report. Therefore, the classification is MANG with high confidence.
2025-10-28 Chinese
《董事、高级管理人员持有和买卖本公司股票管理制度》（2025年10月）
Governance Information Classification · 95% confidence The document is a detailed management system outlining the rules and regulations for directors and senior management personnel regarding their holdings and trading of the company's shares. It references compliance with various securities laws and stock exchange regulations, and includes procedures for reporting, restrictions on trading periods, and penalties for violations. There is no indication that this is an announcement of a report, a financial statement, or a regulatory filing of another type. The content is focused on internal governance and management of insider trading and shareholding by directors and senior management. This fits the definition of a Remuneration Information or Director's Dealing report, but since it is a management system document about shareholding and trading rules rather than a report of actual transactions, it is best classified as Governance Information (CGR), which covers internal rules and governance practices related to board and management conduct.
2025-10-28 Chinese
《信息披露管理制度》（2025年10月）
Governance Information Classification · 95% confidence The document is titled as an "Information Disclosure Management System" for a company, detailing comprehensive rules and procedures for information disclosure, including references to annual reports, interim reports, quarterly reports, audit requirements, and regulatory compliance with Chinese and Hong Kong securities laws. It extensively covers the content and timing of periodic reports (annual, interim, quarterly), audit reports, and temporary reports, as well as disclosure obligations for significant events, transactions, and related party dealings. The document is a detailed internal policy or governance document rather than an actual financial report or announcement. It does not contain financial data or results but rather prescribes how and when such reports and disclosures should be made. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices, including disclosure policies.
2025-10-28 Chinese
《董事会审计委员会工作细则》（2025年10月）
Governance Information Classification · 95% confidence The document is titled as the "Board Audit Committee Working Rules" of a company, detailing the structure, responsibilities, and procedures of the audit committee under the board of directors. It extensively covers governance, audit oversight, internal control, and compliance with laws and listing rules. There is no financial data, no financial statements, no earnings information, no voting results, no announcements of report publication, or any other typical report content. The document is a governance-related internal rules document about the audit committee's operation and duties, which fits the definition of Governance Information (CGR).
2025-10-28 Chinese
关于修订《公司章程》的公告
Governance Information Classification · 95% confidence The document is a detailed announcement regarding the revision of the company's Articles of Association (公司章程). It includes extensive legal and regulatory references, detailed changes to governance structures, shareholder rights, board responsibilities, and internal rules. The content focuses on governance practices, board and shareholder meeting procedures, and compliance with laws and stock exchange rules. There is no financial data, earnings information, or audit results presented. The document is not a report of financial performance or an earnings release, nor is it a simple announcement of a report. It is a governance-related document detailing the company's internal rules and governance practices. Therefore, the most appropriate classification is Governance Information (CGR).
2025-10-28 Chinese
2025年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2025 年第三季度报告" which translates to "2025 Third Quarter Report". It contains detailed financial data including income statements, balance sheets, and cash flow information for the third quarter of 2025. The document includes comprehensive financial metrics, segment revenue, shareholder information, and notes on significant events during the quarter. It explicitly states it is a quarterly report and includes actual financial statements and analysis for the period ending September 30, 2025. The length of the document (15,000 characters) and the detailed financial content confirm it is a full interim/quarterly financial report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2025-10-28 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.